| 2024-02-20 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 24,888 0.0736% | $14.11 | $351,289 | -13.77% | |
| 2024-02-14 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 58,356 0.158% | $15.01 | $875,883 | -17.19% | |
| 2024-02-01 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 10,000 0.0316% | $16.22 | $162,198 | -23.57% | |
| 2023-12-27 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 30,000 0.0868% | $12.02 | $360,453 | +0.92% | |
| 2023-11-20 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 14,807 0.0433% | $8.23 | $121,851 | +46.46% | |
| 2023-08-18 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 14,876 0.0432% | $10.73 | $159,602 | +5.29% | |
| 2023-05-18 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 5,627 0.0194% | $10.14 | $57,083 | +3.03% | |
| 2023-02-17 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 6,700 0.0224% | $7.66 | $51,322 | +18.6% | |
| 2022-11-18 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 1,785 0.0067% | $5.44 | $9,710 | +67.58% | |
| 2022-09-02 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 1,320 0.0057% | $17.01 | $22,458 | -50.12% | |
| 2022-08-17 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 1,797 0.0072% | $14.96 | $26,890 | -47.04% | |
| 2022-03-09 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 10,000 0.0411% | $17.07 | $170,693 | -46.85% | |
| 2021-10-01 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 10,000 0.0406% | $17.18 | $171,841 | -19.73% | |
| 2021-07-01 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 10,000 0.0404% | $24.15 | $241,477 | -36.83% | |
| 2021-06-17 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 1,067 0.0044% | $30.04 | $32,051 | -46.71% | |
| 2021-06-09 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 8,933 0.0375% | $30.05 | $268,480 | -45.22% | |
| 2021-04-01 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 10,000 0.0523% | $27.44 | $274,436 | -34.2% | |
| 2021-02-23 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 10,000 0.0517% | $33.55 | $335,538 | -41.53% | |
| 2021-01-04 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 10,000 0.056% | $18.19 | $181,904 | +13.05% | |
| 2020-10-21 | Sale | KalVista Pharmaceuticals, Inc. KALV | CEO | 22,545 0.1443% | $18.33 | $413,247 | +27.86% |